Literature DB >> 8824727

Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis.

A van den Berg1, M F Hulsbeek, D de Jong, K Kok, P M Veldhuis, J Roche, C H Buys.   

Abstract

In a loss of heterozygosity analysis of 3p, we examined 44 sporadic cases of renal cell carcinoma (RCC) and matched normal tissue with 18 markers distributed over the whole p-arm. The majority of these markers clustered in three regions that have been suggested to be involved in the development of RCC, namely the p25 region, where the von Hippel Lindau (VHL) gene is located; the p21 region, which has been identified as a common region of overlap (SRO) of heterozygous deletions; and the p14 region, which is the location of the constitutional t(3;8) breakpoint occurring in an RCC family. Thirty-one out of these 44 tumors were analyzed with 9 additional markers from the 3p12-14 region to further delimit the SRO in this region. Our analysis shows that when deletions were detected the 3p21 region was always included. The 3p21 markers D3F15S2 and UBEIL were always contained within these 3p21 deletions. The t(3;8) breakpoint region showed the lowest percentage of loss of heterozygosity. Moreover, in three cases the t(3;8) breakpoint region retained heterozygosity, whereas a region more proximal to the breakpoint showed allelic losses. This supports exclusion of the t(3;8) region from a role in the development of sporadic RCC. In a number of tumors, two or three 3p regions with allelic losses were present separated by a region of retention of heterozygosity. In these tumors, deletions at 3p21 occurred in combination with deletions of either the VHL region, or the region proximal to the t(3;8), or both, suggestive of multiple gene involvement in the development of sporadic RCC with a primary role of the 3p21 region.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824727     DOI: 10.1002/(SICI)1098-2264(199601)15:1<64::AID-GCC9>3.0.CO;2-2

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.

Authors:  D Bodmer; M J Eleveld; M J Ligtenberg; M A Weterman; B A Janssen; D F Smeets; P E de Wit; A van den Berg; E van den Berg; M I Koolen; A Geurts van Kessel
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

2.  Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.

Authors:  P Hadaczek; J Podolski; A Toloczko; G Kurzawski; A Sikorski; P Rabbitts; K Huebner; J Lubinski
Journal:  Virchows Arch       Date:  1996-09       Impact factor: 4.064

3.  A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.

Authors:  D C Chung; A P Smith; D N Louis; F Graeme-Cook; A L Warshaw; A Arnold
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

4.  The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.

Authors:  K Dreijerink; E Braga; I Kuzmin; L Geil; F M Duh; D Angeloni; B Zbar; M I Lerman; E J Stanbridge; J D Minna; A Protopopov; J Li; V Kashuba; G Klein; E R Zabarovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

5.  Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis.

Authors:  A Martinez; P Fullwood; K Kondo; T Kishida; M Yao; E R Maher; F Latif
Journal:  Mol Pathol       Date:  2000-06

6.  Renal Cell Carcinoma Metastatic to the Thyroid Gland: A Comparative Molecular Study Between the Primary and the Metastatic Tumor.

Authors:  Xavier Matias-Guiu; Arnald Garcia; Roma Curell; Jaime Prat
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

7.  Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites.

Authors:  K Dolan; J Garde; J Gosney; M Sissons; T Wright; A N Kingsnorth; S J Walker; R Sutton; S J Meltzer; J K Field
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

8.  miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma.

Authors:  Wei Xiang; Jun He; Chao Huang; Lejun Chen; Dan Tao; Xinchao Wu; Miao Wang; Gang Luo; Xingyuan Xiao; Fuqing Zeng; Guosong Jiang
Journal:  Oncotarget       Date:  2015-02-28

9.  Roles of Loss of Chromosome 14q Allele in the Prognosis of Renal Cell Carcinoma with C-reactive Protein Abnormity.

Authors:  Gang Wang; Da-Ming Zhang; Hai-Ying Zhuang; Chao Yin; Jing Liu; Zi-Chun Wang; Li-Cheng Cai; Ming-Hua Ren; Wan-Hai Xu; Cheng Zhang
Journal:  Chin Med J (Engl)       Date:  2017-09-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.